microdosing 2.jpg

Dementia

Various types of neurological disorders affect millions of people around the world, including 24 million that suffer from Alzheimer’s disease. Moreover, as human life expectancy increases at an ever-faster rate, the probability of being affected by dementia rises. With the failures of the healthcare system to provide

at-home neurorecovery solutions,

which would provide accessibility to those unable to easily commute to receive in-person therapy; Ixtlan Bioscience is focused on developing its novel and proprietary Ixtlan AD Kit, for the at-home treatment of patients suffering from Alzheimer’s and dementia diseases. 

color.jpg

Dementia in numbers

46.8m

2015

2030

74.7m

131.5m

2050

Contact Us

contact@ixtlanbioscience.com 


Ixtlan Bioscience

Caesarea Industrial Zone,

Caesarea, Israel

Follow Us
  • 1
  • 2
  • 3